SITC Cancer Immunotherapy CONNECT


Submit Your Research to the 32nd Annual Meeting & Pre-Conference Programs

Submit your research by August 1 to SITC 2017, the premier destination for scientific exchange, education and networking in the cancer immunotherapy field.

Submit Your Abstract TODAY


Begin your free online education today at SITC Cancer Immunotherapy connectED

SITC connectED is the new adaptive learning portal connecting users to online educational activities about cancer immunotherapy with opportunities for continuing education credits. Start with Introduction to Immunology lead by Christian Capitini, MD (University of Wisconsin).

Explore SITC connectED



SITC members who purchase Cancer Immunotherapy Principles and Practice receive a 20 percent discount and free shipping with a promo code.*

member-ribbon-v4.png*Available only when ordering from Demos Medical Publishing

Learn More


June is Cancer Immunotherapy Month

Support the Society for Immunotherapy of Cancer and the cancer immunotherapy field in general during Cancer Immunotherapy Month. Click here to learn all of the ways you can expand your knowledge base and help progress the field forward.

Become Involved

Non-Small Cell Lung Cancer Immunotherapy: Clinical Management

Complete this FREE online CME/CNE activity to learn more about immunotherapy for non-small cell lung cancer, then engage your patients in discussion today!

*Current as of August 2016

Earn Your Credit

2017 Advances in Cancer Immunotherapy™ – Los Angeles

Learn basic immunology principles, the mechanisms and clinical applications of immunotherapy for disease states with FDA-approved treatments and much more. Register on-site on June 29 in Los Angeles for our Advances in Cancer Immunotherapy™ program, SITC's regional cancer immunotherapy education series.

Join us in Los Angeles


Join the Discussion – Create a SITC Cancer Immunotherapy CONNECT Account

Learn and share information in the new SITC Cancer Immunotherapy CONNECT Open Forum! Follow a few easy steps to create a free SITC CONNECT account, upload a profile photo and join the conversation.



Explore resources and educational opportunities for cancer patients and those who advocate for them.







Track the latest advancements and educational opportunities in cancer immunotherapy and immunology.







Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.






Latest Discussions

  • tumour quiescence or dormancy is a state of peculiar equilibrium between cancer and immune cells as far as I know. Dormant prostate cancer cells can be found in elderly men that died of other than cancer cause. It also explains how breast cancer recurs ...

    1 person recommends this.
  • Hi Dr. Lawson,      Like Dr. Hyde, I try to taper down the dex, usually aiming for 0 or 1mg daily. However, if they have neuro symptoms, I still believe there is a role for stereotactic radiosurgery before starting the systemic therapy. Ideally, I taper ...

    1 person recommends this.
  • Can we take out quiescent ( and maybe even senescent) cancer cells with immunotherapy? It is a million dollar question. If we can, the implication would be huge since quiescent cells are believed to be partially responsible for cancer recurrence and senescent ...

    1 person recommends this.

Follow the SITC Twitter Feed.


Connect with colleagues at these Upcoming Events.


Ignite the Sparkathon

Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.


Learn More


Publications & Resources

Journal for ImmunoTherapy of Cancer

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Learn More


Making Cure a Reality

It is the mission of the Society for Immunotherapy of Cancer to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.


Learn More